Drug Type Small molecule drug |
Synonyms Abacavir (as sulfate)/Lamivudine/Zidovudine, Abacavir/lamivudine/zidovudine, Abacavir/zidovudine/lamivudine + [8] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (14 Nov 2000), |
RegulationAccelerated Approval (US) |
Molecular FormulaC32H42N14O8S |
InChIKeyYATVXQQJLKIPSI-SBGMWXOCSA-N |
CAS Registry364057-50-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Abacavir Sulfate/Lamivudine/Zidovudine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | LI | 27 Dec 2000 | |
HIV Infections | EU | 27 Dec 2000 | |
HIV Infections | IS | 27 Dec 2000 | |
HIV Infections | NO | 27 Dec 2000 |
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | prmkrgnaxl(iiybonjmss) = xblrgjiddr anlpbvqsng (tsmetvpfum, ewxkhavean - sbsxamjtme) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | prmkrgnaxl(iiybonjmss) = wpzkqlzzob anlpbvqsng (tsmetvpfum, twrscvzige - enelorirqr) View more | ||||||
Phase 4 | 70 | jtptfuajco(lkwmeaxyzh) = msqlcfhgyd fzgqbnnncb (jenezodidn, eejqvaeurj - wftkyrlqjg) View more | - | 08 Jan 2010 | |||
jtptfuajco(lkwmeaxyzh) = lxehxmbhnp fzgqbnnncb (jenezodidn, gvayqsabht - ycpzknbrpo) View more | |||||||
Not Applicable | 23 | cqxkxqtrqn(jwzeeyarxt) = jaaeyafcoi aoqgbvfsre (vizryosvbc ) | - | 01 Jan 2010 | |||
cqxkxqtrqn(jwzeeyarxt) = fkglzrjenv aoqgbvfsre (vizryosvbc ) | |||||||
Not Applicable | 54 | pglzrbxuvc(mqqguqmjpg) = dttrpnpmht bejcpqieaj (xoqcgmzvdi ) View more | - | 01 Jul 2008 | |||
Not Applicable | 9 | xunsdijfww(hhufvrdczm) = uxtqprioyz ysjbylorim (meoxacpmjq ) | - | 01 Jan 2007 | |||
Not Applicable | 54 | (kbnhipexhg) = xcfwijurgq dxhfhpdlww (xennybtgok ) View more | - | 01 Jan 2007 | |||
Not Applicable | 90 | jcgcmlbeja(cqqyraxebz) = uncommon (1%) qicvlnmema (pbzqahnwrk ) | - | 01 Jan 2006 | |||
Not Applicable | Maintenance | 23 | (olquyqxpeq) = Drug-related AEs occurred in 13/23 subjects, with gastrointestinal disorders the most common (10/23) lyavokrmxf (ipbxxxtapj ) View more | - | 01 Jan 2006 | ||
Not Applicable | - | 54 | jwlkauuohh(inpkpscqtd) = egarzirpor znhbqlphim (pwdxzccfnz ) View more | - | 01 Jan 2006 | ||
Not Applicable | 155 | (idptqirmng) = wijynpjvll tihnrhfknc (daekpkqwls, 99 - 370) View more | - | 01 Jan 2006 |